Connection

Timothy Lyons to Non-alcoholic Fatty Liver Disease

Back to Details
This is a "connection" page, showing publications Timothy Lyons has written about Non-alcoholic Fatty Liver Disease.
Timothy Lyons
Connection Strength
0.187
Non-alcoholic Fatty Liver Disease
  1. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. Am J Physiol Endocrinol Metab. 2020 02 01; 318(2):E131-E144.
    View in: PubMed
    Score: 0.153
  2. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. Am J Physiol Endocrinol Metab. 2018 11 01; 315(5):E745-E757.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.